Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva and Gemcitabine in Pancreatic Cancer
NCT00461708Phase 2Completed
- Sponsor
- Roche
- Start
- May 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in pancreatic cancer (PC), sponsored by Roche. Started May 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00461708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461708.